Latest Press Releases Aug 22 2024 Vertex to Participate in Upcoming September Investor Conferences Read More Aug 07 2024 Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England Read More Aug 01 2024 Vertex Reports Second Quarter 2024 Financial Results Read More Jul 30 2024 Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain Read More Jul 02 2024 Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis Read More Jul 01 2024 Vertex to Announce Second Quarter 2024 Financial Results on August 1 Read More Load More Recent Media Library Items View All Date - Any -2021202220232024 Tags Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAExecutive ChairmanExecutive Vice President and Chief Financial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Corporate Fact Sheet Download 1 MB Date - Any -2021202220232024 Tags Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAExecutive ChairmanExecutive Vice President and Chief Financial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Jeffrey Leiden, M.D., Ph.D. Executive Chairman Download Date - Any -2021202220232024 Tags Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAExecutive ChairmanExecutive Vice President and Chief Financial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Vertex International Headquarters Paddington – Lobby Download 915 KB Date - Any -2021202220232024 Tags Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAExecutive ChairmanExecutive Vice President and Chief Financial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Vertex Logo with Tagline Download 2 MB | 2951 x 1952 Mediainfo@VRTX.com
Aug 07 2024 Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England Read More
Jul 30 2024 Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain Read More
Jul 02 2024 Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis Read More
